Cargando…

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial

BACKGROUND: Radiotherapy‐induced esophagitis (RE) diminishes the quality of life and interrupts treatment in patients with non‐small cell lung cancer (NSCLC) undergoing postoperative radiotherapy. Dosimetric models showed limited capability in predicting RE. We aimed to develop dosiomic models to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zeliang, Liang, Bin, Wei, Ran, Liu, Yunsong, Bao, Yongxing, Yuan, Meng, Men, Yu, Wang, Jianyang, Deng, Lei, Zhai, Yirui, Bi, Nan, Wang, Luhua, Dai, Jianrong, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542460/
https://www.ncbi.nlm.nih.gov/pubmed/37596813
http://dx.doi.org/10.1111/1759-7714.15068
_version_ 1785114098994774016
author Ma, Zeliang
Liang, Bin
Wei, Ran
Liu, Yunsong
Bao, Yongxing
Yuan, Meng
Men, Yu
Wang, Jianyang
Deng, Lei
Zhai, Yirui
Bi, Nan
Wang, Luhua
Dai, Jianrong
Hui, Zhouguang
author_facet Ma, Zeliang
Liang, Bin
Wei, Ran
Liu, Yunsong
Bao, Yongxing
Yuan, Meng
Men, Yu
Wang, Jianyang
Deng, Lei
Zhai, Yirui
Bi, Nan
Wang, Luhua
Dai, Jianrong
Hui, Zhouguang
author_sort Ma, Zeliang
collection PubMed
description BACKGROUND: Radiotherapy‐induced esophagitis (RE) diminishes the quality of life and interrupts treatment in patients with non‐small cell lung cancer (NSCLC) undergoing postoperative radiotherapy. Dosimetric models showed limited capability in predicting RE. We aimed to develop dosiomic models to predict RE. METHODS: Models were trained with a real‐world cohort and validated with PORT‐C randomized controlled trial cohort. Patients with NSCLC undergoing resection followed by postoperative radiotherapy between 2004 and 2015 were enrolled. The endpoint was grade ≥2 RE. Esophageal three‐dimensional dose distribution features were extracted using handcrafted and convolutional neural network (CNN) methods, screened using an entropy‐based method, and selected using minimum redundancy and maximum relevance. Prediction models were built using logistic regression. The areas under the receiver operating characteristic curve (AUC) and precision‐recall curve were used to evaluate prediction model performance. A dosimetric model was built for comparison. RESULTS: A total of 190 and 103 patients were enrolled in the training and validation sets, respectively. Using handcrafted and CNN methods, 107 and 4096 features were derived, respectively. Three handcrafted, four CNN‐extracted and three dosimetric features were selected. AUCs of training and validation sets were 0.737 and 0.655 for the dosimetric features, 0.730 and 0.724 for handcrafted features, and 0.812 and 0.785 for CNN‐extracted features, respectively. Precision‐recall curves revealed that CNN‐extracted features outperformed dosimetric and handcrafted features. CONCLUSIONS: Prediction models may identify patients at high risk of developing RE. Dosiomic models outperformed the dosimetric‐feature model in predicting RE. CNN‐extracted features were more predictive but less interpretable than handcrafted features.
format Online
Article
Text
id pubmed-10542460
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-105424602023-10-03 Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial Ma, Zeliang Liang, Bin Wei, Ran Liu, Yunsong Bao, Yongxing Yuan, Meng Men, Yu Wang, Jianyang Deng, Lei Zhai, Yirui Bi, Nan Wang, Luhua Dai, Jianrong Hui, Zhouguang Thorac Cancer Original Articles BACKGROUND: Radiotherapy‐induced esophagitis (RE) diminishes the quality of life and interrupts treatment in patients with non‐small cell lung cancer (NSCLC) undergoing postoperative radiotherapy. Dosimetric models showed limited capability in predicting RE. We aimed to develop dosiomic models to predict RE. METHODS: Models were trained with a real‐world cohort and validated with PORT‐C randomized controlled trial cohort. Patients with NSCLC undergoing resection followed by postoperative radiotherapy between 2004 and 2015 were enrolled. The endpoint was grade ≥2 RE. Esophageal three‐dimensional dose distribution features were extracted using handcrafted and convolutional neural network (CNN) methods, screened using an entropy‐based method, and selected using minimum redundancy and maximum relevance. Prediction models were built using logistic regression. The areas under the receiver operating characteristic curve (AUC) and precision‐recall curve were used to evaluate prediction model performance. A dosimetric model was built for comparison. RESULTS: A total of 190 and 103 patients were enrolled in the training and validation sets, respectively. Using handcrafted and CNN methods, 107 and 4096 features were derived, respectively. Three handcrafted, four CNN‐extracted and three dosimetric features were selected. AUCs of training and validation sets were 0.737 and 0.655 for the dosimetric features, 0.730 and 0.724 for handcrafted features, and 0.812 and 0.785 for CNN‐extracted features, respectively. Precision‐recall curves revealed that CNN‐extracted features outperformed dosimetric and handcrafted features. CONCLUSIONS: Prediction models may identify patients at high risk of developing RE. Dosiomic models outperformed the dosimetric‐feature model in predicting RE. CNN‐extracted features were more predictive but less interpretable than handcrafted features. John Wiley & Sons Australia, Ltd 2023-08-19 /pmc/articles/PMC10542460/ /pubmed/37596813 http://dx.doi.org/10.1111/1759-7714.15068 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Ma, Zeliang
Liang, Bin
Wei, Ran
Liu, Yunsong
Bao, Yongxing
Yuan, Meng
Men, Yu
Wang, Jianyang
Deng, Lei
Zhai, Yirui
Bi, Nan
Wang, Luhua
Dai, Jianrong
Hui, Zhouguang
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title_full Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title_fullStr Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title_full_unstemmed Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title_short Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
title_sort enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: dosiomic model development in a real‐world cohort and validation in the port‐c randomized controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542460/
https://www.ncbi.nlm.nih.gov/pubmed/37596813
http://dx.doi.org/10.1111/1759-7714.15068
work_keys_str_mv AT mazeliang enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT liangbin enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT weiran enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT liuyunsong enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT baoyongxing enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT yuanmeng enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT menyu enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT wangjianyang enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT denglei enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT zhaiyirui enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT binan enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT wangluhua enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT daijianrong enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial
AT huizhouguang enhancedpredictionofpostoperativeradiotherapyinducedesophagitisinnonsmallcelllungcancerdosiomicmodeldevelopmentinarealworldcohortandvalidationintheportcrandomizedcontrolledtrial